Company
Every investor coverage indicates participated in a round Avance Clinical raised.
Investors whose own portfolio pages list Avance Clinical, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Genesis Capital | its portfolio page ↗ |
Companies Avance Clinical acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Ben Edwards | Chief Strategy Officer | Startup Daily |
Stories naming Avance Clinical. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Clinical trials platform Evrima has secured $3 million in a round led by Artesian's Sydney arm, the first deal through its new Female Leaders VC Fund, with BridgeLane Capital and Wavemaker Partners taking part.